The complexity of pancreatic ductal cancers and multidimensional strategies for therapeutic targeting

Research output: Contribution to journalReview article

Abstract

The directions of differentiation and the molecular features of ductal pancreatic cancer have by now been explored in reasonable detail. Already, diagnoses and therapeutic strategies benefit from observations distinguishing the major variant types of pancreatic cancer and the differing stages of disease at presentation. Additionally, individual patients differ within each variant type. In certain high-risk groups, this permits focused screening efforts. The tumorigenic influences that characterize individual patients are increasingly considered appropriate in defining clinical treatment plans. As a result, multiple variables affect success when individualizing screening or therapy. These competing variables often limit the potential for success: some variables dominate and should receive greater consideration than others. Simplistic expectations, often falsely optimistic, for individualized care may fail to 'pan out' in the real world. The development of individualized care will be efficient only when the full complexity of the disease is embraced.

Original languageEnglish (US)
Pages (from-to)296-307
Number of pages12
JournalJournal of Pathology
Volume223
Issue number2
DOIs
StatePublished - Jan 2011

Keywords

  • carcinoma
  • gene
  • genetic
  • heterogeneity
  • pancreas
  • personalized treatment
  • therapy

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Fingerprint Dive into the research topics of 'The complexity of pancreatic ductal cancers and multidimensional strategies for therapeutic targeting'. Together they form a unique fingerprint.

  • Cite this